The ALINA trial was presented in the Presidential Session at ESMO 2023 by Prof...
The ESMO 2023 conference featured exciting data on lung cancer, including...
Prof Herbert Loong, representing the Chinese University of Hong Kong, presented...
At ESMO 2023, the results of the Papillon study, a phase 3 trial comparing...
Until now, a single TKI has been the standard treatment in patients with...